Cargando…
Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
BACKGROUND: The aim of this study is to profile the cytokines and immune cells of body fluid from metastatic gastric cancer (mGC), and evaluate the potential role as a prognostic factor and the feasibility as a predictive biomarker or monitoring source for immune checkpoint inhibitor. METHODS: Body...
Autores principales: | Park, Hyung Soon, Kwon, Woo Sun, Park, Sejung, Jo, Eunji, Lim, So Jung, Lee, Choong-kun, Lee, Jii Bum, Jung, Minkyu, Kim, Hyo Song, Beom, Seung-Hoon, Park, Jun Yong, Kim, Tae Soo, Chung, Hyun Cheol, Rha, Sun Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805480/ https://www.ncbi.nlm.nih.gov/pubmed/31639056 http://dx.doi.org/10.1186/s40425-019-0708-8 |
Ejemplares similares
-
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019) -
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy
por: Jung, Seung-Hyun, et al.
Publicado: (2023) -
Detection of asymptomatic recurrence improves survival of gastric cancer patients
por: Park, Ji Soo, et al.
Publicado: (2021) -
Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
por: Lee, Jii Bum, et al.
Publicado: (2021) -
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)